会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • ANTITUMORAL ANALOGS
    • 抗肿瘤模拟
    • WO2003014127A1
    • 2003-02-20
    • PCT/GB2002/003592
    • 2002-08-06
    • PHARMA MAR, S.A.MARTINEZ, ValentinGALLEGO, PilarCUEVAS, CarmenMUNT, SimonMANZANARES, Ignacio
    • MARTINEZ, ValentinGALLEGO, PilarCUEVAS, CarmenMUNT, SimonMANZANARES, Ignacio
    • C07D515/22
    • C07D515/22
    • Derivatives of ecteinascidin 736 of general formula (I) wherein the groups R 1 , R 2 , R 3 , R 4 and R 5 are each independently selected from the group consisting of H, OH, OR', SH, SR', SOR', SO 2 R', C(=O)R', C(=O)OR', NO 2 , NH 2 , NHR', N(R') 2 , NHC(O)R', CN, halogen, =O, substituted or unsubstituted C 1 -C 25 alkyl, substituted or unsubstituted C 2 -C 18 alkenyl, substituted or unsubstituted C 2 -C 18 alkynyl, substituted or unsubstituted arly, substituted or unsubstituted heterocyclic; wherein X is independently selected of OR', CN, (=O), or H; wherein each of the R' groups is independently selected from the group consisting of H, OH, NO 2 , NH 2 , SH, CN, halogen, =O, C(=O)H, C(=O)CH 3 , CO 2 H, substituted or unsubstituted C 1 -C 25 alkyl, substituted or unsubstituted C 2 -C 18 alkenyl, substituted or unsubstituted C 2 -C 18 alkynyl, substituted or unsubstituted aryl; wherein m is 0, 1 or 2; and wherein n is 0, 1, 2, 3, or 4, and their use as antitumoral agent.
    • 基团R 1,R 2,R 3,R 4和R 5各自独立地选自H,OH,OR',SH,SR',SOR',SO 2 R',C的通式(I)的抗坏血酸素736衍生物 (= O)R',C(= O)OR',NO 2,NH 2,NHR',N(R')2,NHC(O)R',CN,卤素,= O,取代或未取代的C 1 -C 25烷基 取代或未取代的C 2 -C 18烯基,取代或未取代的C 2 -C 18炔基,取代或未取代的芳基,取代或未取代的杂环; 其中X独立地选自OR',CN,(= O)或H; 其中每个R'基团独立地选自H,OH,NO 2,NH 2,SH,CN,卤素,= O,C(= O)H,C(= O)CH 3,CO 2 H, 未取代的C 1 -C 25烷基,取代或未取代的C 2 -C 18烯基,取代或未取代的C 2 -C 18炔基,取代或未取代的芳基; 其中m为0,1或2; 并且其中n为0,1,2,3或4,并且其用作抗肿瘤剂。